FCM
VERV

Farallon Capital Management’s Verve Therapeutics VERV Stock Holding History

Farallon Capital Management’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,612,000
Closed -$40.6M – 167
2025
Q2 		$40.6M Buy
3,612,000
+2,700,000
+296% +$15.4M 0.19% 59
2025
Q1 		$4.17M Buy
+912,000
New +$6.11M 0.02% 84
2023
Q4 		– Sell
-211,293
Closed -$2.8M – 166
2023
Q3 		$2.8M Buy
+211,293
New +$3.4M 0.02% 104

Other funds holding VERV

GCM
Greenland Capital Management New York $500M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return